207_Combined course Presentations

 50% of patients with NSCLC did not receive treatment according to the well accepted guidelines

 EBM is based on selected series of patients and is not applicable to an average patient in clinical practice

 Stage III NSCLC: the gap between an ideal patient from the guidelines and the average patient from clinical practice is especially wide

 Vast majority of patients present bulky tumors and/or suffer from significant comorbidity

Zwitter M. J Thorac Oncol. 2012;7